CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-κB upon T-cell activation

Biochemical and Biophysical Research Communications

Volumn 370, Issue 1, 2008, Pages 149-153

  Koh, Han S ^a   Lee, Changjin ^b   Lee, Kwang S ^a   Ham, Chul S ^a   Seong, Rho H ^b   Kim, Sang S ^c   Jeon, Sung H ^a  

^a Hallym University   (South Korea)

^b Research Center for Functional Cellulomics   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

CD7 promoter activity; Galectin 1 induced apoptosis; MSK1; NF B transcription factor; p38 MAPK pathway; TCR CD28

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD7 ANTIGEN; GALECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TRANSCRIPTION FACTOR SP1;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER GROWTH; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ANTIGENS, CD7; APOPTOSIS; DOWN-REGULATION; GALECTIN 1; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LYMPHOCYTE ACTIVATION; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SP1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TCF TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR;

EID: 41849097003     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.049     Document Type: Article

References (32)

1. Osborne B.A. Transcriptional control of T cell development. Curr. Opin. Immunol. 12 (2000) 301-306
2. Ko M., Ahn J., Lee C., Chung H., Jeon S.H., Chung H.Y., and Seong R.H. E2A/HEB and Id3 proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression. J. Biol. chem. 21 (2004) 21916-21923
3. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
4. Khoshnan A., Tindell C., Laux I., Bae D., Bennett B., and Nel A.E. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J. Immunol. 165 (2000) 1743-1754
5. Hettmann T., DiDonato J., Karin M., and Leiden J.M. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189 (1999) 145-158
6. Zhang J., salojin K., Gao J.X., Cameron M., Bergerot I., and Delovitch T. p38 mitogen activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162 (1999) 3819-3829
7. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22 (2003) 1313-1324
8. Olson C.M., Hedrick M.N., Izadi H., Bates T.C., Olivera E.R., and Anguita J. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infection and Immunity 75 (2007) 270-277
9. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
10. Perillo N.L., Pace K.E., Seilhamer J.J., and Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 378 (1995) 736-739
11. Fuertes M.B., Molinero L.L., Toscano M.A., Ilarregui J.M., Rubinstein N., Fainboim L., Zwirner N.W., and Rabinovich G.A. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell. Biochem. 267 (2004) 177-185
12. Heinly C.S., Sempowski G.D., Lee D.M., patel D.D., McDermott P.M., Scearce R.M., Thompson C.B., and Hayne B.F. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice. Int. Immunol. 13 (2001) 157-166
13. Lee D.M., Staats H.F., Sundy J.S., Petal D.D., Sempowski G.D., Scearce R.M., M Jones D., and Haynes B.F. Immunologic characterization of CD7-deficient mice. J. Immunol. 160 (1998) 5749-5759
14. Rappl G., Abken H., Muche J.M., Sterry W., Tilgen W., Andre S., kaltner H., Ugurel S., Gabius H.J., and Reinhold U. CD4+CD7-leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16 (2002) 840-845
15. Rincon M., Tugores A., and Lopez-Botet M. Cyclic AMP and calcium regulate at a transcriptional level the expression of the CD7 leukocyte differentiation antigen. J. Biol. Chem. 267 (1992) 18026-18031
16. Ware R.E., and Haynes B.F. T cell CD7 mRNA expression is regulated by both transcriptional and posttranscriptional mechanisms. Int. Immunol. 5 (1993) 179-187
17. Bonilla F.A., Kokron C.M., Swinton P., and Geha R.S. Targeted gene disruption of murine CD7. Int. Immunol. 9 (1997) 1875-1883
18. Vacchio M.S., and Ashwell J.D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 185 (1997) 2033-2038
19. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. In: Baxevanis A.D., Davison D.B., Page R.D.M., Petsko G.A., Stein L.D., and Stormo G.D. (Eds). Current Protocols in Bioinformatics (2003), John Wiley & Sons, New York (pp. Unit 2.6)
20. Sors A., Jean-Louis F., Pellet C., Laroche L., Dubertret L., Courtois G., Bachelez H., and Michel L. Down-regulating constitutive activation of the NF-kB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 107 (2006) 2354-2363
21. Perkins N.D., Agranoff A.B., Pascal E., and Nabel G.J. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14 (1994) 6570-6583
22. Ghadially H., Ross X.L., Kerst C., Dong J., Reske-Kunz A.B., and Ross R. Differential regulation of CCL22 gene expression in murine dendritic cells and B cells. J. Immunol. 174 (2005) 5620-5629
23. Neish A.S., Khachigian L.M., Park A., Baichwal V.R., and Collins T. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J. Biol. Chem. 181 (1995) 28903-28909
24. Emami K.H., Burke T.W., and Smale S.T. Sp1 activation of a TATA-less promoter requires a species-specific interaction involving transcription factor IID. Nucleic Acids Res. 26 (1998) 839-846
25. Block K.L., Shou Y., and Poncz M. An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 88 (1996) 2071-2080
26. Rudge T.L., and Johnson L.F. Synergistic activation of the TATA-less mouse thymidylate synthase promoter by the Ets transcription factor GABP and Sp1. Exp. Cell Res. 274 (2002) 45-55
27. Tolnay M., Vereshchagina L.A., and Tsokos G.C. NF-kB regulates the expression of the human complement receptor 2 gene. J. Immunol. 169 (2002) 6236-6243
28. Massari M.E., and Murre C. Helix-loop-helix proteins: regulators of transcription in eukaryotic organisms. Mol. Cell. Biol. 20 (2000) 429-440
29. Henthorn P., Kiledjian M., and Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science 247 (1990) 467-470
30. Li L., Cserjesi P., and Olson E.N. Dermo-1: a novel Twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172 (1995) 280-292
31. Baum L.G., Pang M., Perillo N.L., Wu T., Delegeane A., Uittenbogaart C.H., Fukuda M., and Seilhamer J.J. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2-O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181 (1995) 877-887
32. Ma A., Pena J.C., Chang B., Margosian E., Davidson L., Alt F.W., and Thompson C.B. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 4763-4767